Baclofen Side Effects and Toxicity
Baclofen commonly causes transient drowsiness (10-63%), dizziness (5-15%), and weakness (5-15%), while toxicity—particularly at doses ≥200 mg—manifests as CNS depression, seizures, respiratory depression requiring mechanical ventilation, and can be life-threatening if abruptly discontinued. 1, 2
Common Side Effects (Therapeutic Dosing)
The FDA-approved labeling clearly delineates the most frequent adverse reactions 1:
Neurological (Most Common):
- Transient drowsiness: 10-63% (versus 36% placebo)
- Dizziness: 5-15%
- Weakness and fatigue: 5-15% and 2-4% respectively
- Confusion: 1-11%
- Headache: 4-8%
- Insomnia: 2-7%
Cardiovascular:
- Hypotension: 0-9%
- Rare: dyspnea, palpitations, chest pain, syncope
Gastrointestinal:
- Nausea: 4-12%
- Constipation: 2-6%
- Rarely: dry mouth, altered taste, abdominal pain
Genitourinary:
- Urinary frequency: 2-6%
- Rarely: urinary retention, dysuria, impotence
Starting with low doses and gradual titration minimizes these common side effects, particularly dizziness, somnolence, and GI symptoms 3.
Baclofen Toxicity: Clinical Presentation
Doses ≥200-300 mg define the threshold for severe toxicity 2, 4. A systematic review of 1,618 cases demonstrated clear dose-dependent effects:
Neurological Toxicity (Primary Manifestations):
- CNS depression/coma: 68% of cases
- Seizures: 36% of cases
- Delirium and altered mentation
- Hypotonia (paradoxical in a patient normally spastic)
- Absent or depressed deep tendon reflexes
- Pupillary changes: both miosis and mydriasis reported
- Ataxia, dysarthria, nystagmus 1, 2, 4
Respiratory Complications:
- Respiratory depression: 21% of toxicity cases
- Mechanical ventilation required in approximately 54.5% of severe cases
- Rare: atelectasis and pneumomediastinum (from bronchospasm and alveolar rupture) 2, 5
Cardiovascular Effects:
- Hypertension more common than hypotension (particularly with doses >200 mg)
- Sinus bradycardia or tachycardia
- Severe arrhythmias are uncommon 4
Critical Pitfall: In patients with renal impairment, toxicity can occur at normal therapeutic doses due to prolonged half-life, as baclofen is primarily renally excreted. Myoclonus is an underrecognized manifestation in chronic kidney disease patients 6, 7.
Management of Toxicity
Supportive care is the cornerstone of management 2:
- Mechanical ventilation for respiratory depression (needed in >50% of severe cases)
- ICU admission for doses ≥200 mg
- Seizure management with standard anticonvulsants
- Cardiovascular monitoring and support
- Hemodialysis in severe cases, particularly with renal impairment 6, 7
Prognosis: Full clinical recovery occurred in 97.7% of cases with supportive management, and mortality remains low (0-4%) when promptly recognized 2.
Withdrawal Syndrome: A Life-Threatening Emergency
Abrupt discontinuation of baclofen after chronic use causes a potentially fatal withdrawal syndrome, particularly with intrathecal administration 8.
Withdrawal Symptoms (onset 1-4 days after discontinuation):
- Visual and auditory hallucinations
- Severe psychiatric disturbances (up to 20.6% of cases)
- Delirium and agitation
- Anxiety and confusion
- Autonomic instability: fever, tachycardia, tremors
- Seizures
- Rebound spasticity 8, 2
Intrathecal Baclofen Withdrawal (Most Severe):
- High fever
- Altered mental status
- Severe rebound spasticity and muscle rigidity
- Rhabdomyolysis
- Multiorgan failure
- Death if untreated 8
Management of Withdrawal:
- Immediate baclofen reinitiation consistently resolves symptoms 2
- Slow tapering over 2 weeks when discontinuation is planned 8
- Perioperative management requires specialist consultation for intrathecal pumps
- Continue oral baclofen through the day of surgery to prevent withdrawal 8
Special Populations
Renal Impairment: Dose reduction mandatory; toxicity occurs at therapeutic doses due to accumulation 1, 6, 7
Pregnancy: Increased risk of omphaloceles and skeletal ossification delays in animal studies; neonatal withdrawal syndrome reported with symptoms including increased muscle tone, tremor, jitteriness, and seizures. Gradual discontinuation before delivery recommended if feasible 1
Elderly: Higher risk of sedation, falls, and hypotension; use with extreme caution 3